Fluoxetine Hcl Capsule
NDC Package 72189-656-90
Package Information
Fluoxetine Hcl capsules is fluoxetine is used to treat depression, panic attacks, obsessive compulsive disorder, a certain eating disorder (bulimia), and a severe form of premenstrual syndrome (premenstrual dysphoric disorder). This formulation utilizes a capsule delivery system. Marketed by Direct_rx, this product is identified by NDC 72189-656 and is authorized under FDA application ANDA204597.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72189 - Direct_rx
- 72189-656 - Fluoxetine Hcl
- 72189-656-90 - 90 CAPSULE in 1 BOTTLE
- 72189-656 - Fluoxetine Hcl
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (72189-656). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72189-656-90 identifies a specific commercial package of 90 capsule in 1 bottle of Fluoxetine Hcl, a human prescription drug labeled by Direct_rx. This product is billed for "EA" each discreet unit and contains an estimated amount of 90 billable units per package. This capsule is formulated for oral use and contains fluoxetine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Direct_rx on January 15, 2026. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Fluoxetine is used to treat depression, panic attacks, obsessive compulsive disorder, a certain eating disorder (bulimia), and a severe form of premenstrual syndrome (premenstrual dysphoric disorder). This medication may improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living. It may decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. It may also reduce the urge to perform repeated tasks (compulsions such as hand-washing, counting, and checking) that interfere with daily living. Fluoxetine may lessen premenstrual symptoms such as irritability, increased appetite, and depression. It may decrease binging and purging behaviors in bulimia.
How is this Direct_rx product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72189065690. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 90 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.